FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280594706> ?p ?o ?g. }

• W4280594706 abstract "Abstract Background Mild cognitive impairment in Parkinson’s disease (PD-MCI) is associated with an increased risk of cognitive decline. PD-MCI is characterized by impairments in executive function and visuospatial recognition. The visuospatial n-back test is useful for assessing both domains. The 0-back test reflects visuospatial recognition, while the 1-back and 2-back tests reflect working memory. Cholinesterase inhibitors are effective in the treatment of PD-MCI and dementia in PD (PDD). Although some studies have reported the efficacy of memantine for PDD, the therapeutic efficacy of memantine in patients with PD-MCI remains uncertain. Methods This study aimed to investigate the effects of memantine on brain function in patients with PD-MCI, using a randomized double-blinded crossover protocol and functional MRI (fMRI). Ten patients who completed 16 weeks of follow-up were included. They were randomly assigned to either the memantine or placebo. Patients in the memantine group received 5 mg/day of memantine in the first week. The memantine dose was increased by 5 mg/day per week, until a final dose of 20 mg/day. Patients in the placebo group received the placebo following the same regimen as memantine. After the intervention, they underwent a 4 weeks washout period. Following the crossover protocol, a second intervention was conducted after the washout period. In each intervention, fMRI and neuropsychological tests were performed at the maximum dose period. Comparing the memantine and placebo groups, we investigated difference in the brain regions using the visuospatial n-back test. Results There were no significant regions enhanced by memantine comparing with placebo at any load of n-back tests. In contrast, exploring regions reduced by memantine, we found significant reduction of activations within right lingual gyrus and left superior frontal gyrus in comparison between 2-back and 0-back test. A number of correct answers of the 2-back test and time to complete Trail Making Test-A were worse during memantine intervention. Conclusions Memantine did not improve visuospatial working memory of the patients with PD-MCI. Treatment for PD should be planned carefully considering the impact on cognitive function. Further study is needed to establish new therapeutic strategy. Trial registration UMIN000046104. Retrospectively registered. First registration date: 28 Sept 2017." @default.
• W4280594706 created "2022-05-22" @default.
• W4280594706 creator A5002007939 @default.
• W4280594706 creator A5015238037 @default.
• W4280594706 date "2022-05-13" @default.
• W4280594706 modified "2023-10-18" @default.
• W4280594706 title "Memantine for the patients with mild cognitive impairment in Parkinson’s disease: a pharmacological fMRI study" @default.
• W4280594706 cites W1631771704 @default.
• W4280594706 cites W1743297306 @default.
• W4280594706 cites W1894821530 @default.
• W4280594706 cites W1921280105 @default.
• W4280594706 cites W197066864 @default.
• W4280594706 cites W1974474435 @default.
• W4280594706 cites W197750504 @default.
• W4280594706 cites W1979395839 @default.
• W4280594706 cites W1989070599 @default.
• W4280594706 cites W1992135961 @default.
• W4280594706 cites W1999358054 @default.
• W4280594706 cites W2006115291 @default.
• W4280594706 cites W2014084349 @default.
• W4280594706 cites W2036439678 @default.
• W4280594706 cites W2044384631 @default.
• W4280594706 cites W2046187238 @default.
• W4280594706 cites W2056145524 @default.
• W4280594706 cites W2064963539 @default.
• W4280594706 cites W2083925654 @default.
• W4280594706 cites W2085864311 @default.
• W4280594706 cites W2088041935 @default.
• W4280594706 cites W2089085990 @default.
• W4280594706 cites W2092356280 @default.
• W4280594706 cites W2093899264 @default.
• W4280594706 cites W2101511977 @default.
• W4280594706 cites W2102508576 @default.
• W4280594706 cites W2105801762 @default.
• W4280594706 cites W2108310775 @default.
• W4280594706 cites W2111443780 @default.
• W4280594706 cites W2114293963 @default.
• W4280594706 cites W2128443648 @default.
• W4280594706 cites W2129036744 @default.
• W4280594706 cites W2133342484 @default.
• W4280594706 cites W2136332296 @default.
• W4280594706 cites W2156013560 @default.
• W4280594706 cites W2160660329 @default.
• W4280594706 cites W2166609052 @default.
• W4280594706 cites W2168463394 @default.
• W4280594706 cites W2169925926 @default.
• W4280594706 cites W2400155502 @default.
• W4280594706 cites W2522916970 @default.
• W4280594706 cites W2576639105 @default.
• W4280594706 cites W2621721356 @default.
• W4280594706 cites W2913107679 @default.
• W4280594706 cites W2992906473 @default.
• W4280594706 cites W3113125494 @default.
• W4280594706 doi "https://doi.org/10.1186/s12883-022-02699-x" @default.
• W4280594706 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35562711" @default.
• W4280594706 hasPublicationYear "2022" @default.
• W4280594706 type Work @default.
• W4280594706 citedByCount "2" @default.
• W4280594706 countsByYear W42805947062023 @default.
• W4280594706 crossrefType "journal-article" @default.
• W4280594706 hasAuthorship W4280594706A5002007939 @default.
• W4280594706 hasAuthorship W4280594706A5015238037 @default.
• W4280594706 hasBestOaLocation W42805947061 @default.
• W4280594706 hasConcept C118552586 @default.
• W4280594706 hasConcept C126322002 @default.
• W4280594706 hasConcept C142724271 @default.
• W4280594706 hasConcept C15744967 @default.
• W4280594706 hasConcept C16568411 @default.
• W4280594706 hasConcept C168563851 @default.
• W4280594706 hasConcept C204787440 @default.
• W4280594706 hasConcept C27081682 @default.
• W4280594706 hasConcept C2779134260 @default.
• W4280594706 hasConcept C2779483572 @default.
• W4280594706 hasConcept C2779484449 @default.
• W4280594706 hasConcept C2780904820 @default.
• W4280594706 hasConcept C39920043 @default.
• W4280594706 hasConcept C71924100 @default.
• W4280594706 hasConcept C87813604 @default.
• W4280594706 hasConceptScore W4280594706C118552586 @default.
• W4280594706 hasConceptScore W4280594706C126322002 @default.
• W4280594706 hasConceptScore W4280594706C142724271 @default.
• W4280594706 hasConceptScore W4280594706C15744967 @default.
• W4280594706 hasConceptScore W4280594706C16568411 @default.
• W4280594706 hasConceptScore W4280594706C168563851 @default.
• W4280594706 hasConceptScore W4280594706C204787440 @default.
• W4280594706 hasConceptScore W4280594706C27081682 @default.
• W4280594706 hasConceptScore W4280594706C2779134260 @default.
• W4280594706 hasConceptScore W4280594706C2779483572 @default.
• W4280594706 hasConceptScore W4280594706C2779484449 @default.
• W4280594706 hasConceptScore W4280594706C2780904820 @default.
• W4280594706 hasConceptScore W4280594706C39920043 @default.
• W4280594706 hasConceptScore W4280594706C71924100 @default.
• W4280594706 hasConceptScore W4280594706C87813604 @default.
• W4280594706 hasIssue "1" @default.
• W4280594706 hasLocation W42805947061 @default.
• W4280594706 hasLocation W42805947062 @default.
• W4280594706 hasLocation W42805947063 @default.
• W4280594706 hasLocation W42805947064 @default.
• W4280594706 hasOpenAccess W4280594706 @default.
• W4280594706 hasPrimaryLocation W42805947061 @default.

• next